Condition:   Cytomegalovirus Infection
Interventions:   Biological: Adoptive Cellular Therapy;   Drug: Best available antiviral drug therapy
Sponsors:   Cell Medica Ltd;   Wellcome Trust;   Choice Pharma Ltd;   Commitum AB;   BioAnaLab
Recruiting - verified February 2010

Condition:   Coronary Artery Disease
Intervention:   Device: Radi pressure wire (pressure wire assessment)
Sponsor:   Southampton University Hospitals NHS Trust
Recruiting - verified October 2009

Conditions:   Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg Strauss Syndrome;   Polyarteritis Nodosa;   Giant Cell Arteritis;   Takayasu Arteritis
Intervention:  
Sponsors:   University of Oxford;   American College of Rheumatology;   The European League Against Rheumatism (EULAR);   The Vasculitis foundation
Not yet recruiting - verified February 2010

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: exenatide once weekly;   Drug: insulin detemir
Sponsors:   Amylin Pharmaceuticals, Inc.;   Eli Lilly and Company
Recruiting - verified December 2009

Condition:   Alzheimer's Disease
Interventions:   Drug: LY2062430;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Recruiting - verified March 2010

Condition:   Toxicity
Intervention:   Other: Pharmacogenomic whole blood sampling
Sponsor:   Takeda Global Research & Development Center, Inc.
Recruiting - verified February 2010

Condition:   Non-small Cell Lung Cancer
Interventions:   Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Placebo;   Drug: Pemetrexed;   Other: Best Supportive Care
Sponsor:   Eli Lilly and Company
Recruiting - verified March 2010

Condition:   Gastrointestinal Stromal Tumor (GIST)
Interventions:   Drug: Nilotinib (AMN107);   Drug: imatinib (STI571)
Sponsor:   Novartis Pharmaceuticals
Recruiting - verified February 2010

Condition:   ADHD
Interventions:   Drug: SPD489 (lisdexamfetamine dimesylate);   Drug: Placebo
Sponsor:   Shire Pharmaceutical Development
Recruiting - verified March 2010

Condition:   ADHD
Interventions:   Drug: LDX;   Drug: Methylphenidate Hydrochloride;   Drug: Placebo
Sponsor:   Shire Pharmaceutical Development
Recruiting - verified February 2010

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Atomoxetine
Sponsor:   Eli Lilly and Company
Recruiting - verified March 2010

Condition:   Non Small Cell Lung Cancer
Interventions:   Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Etoposide;   Drug: Cisplatin;   Drug: Vinorelbine;   Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Thoracic Radiation Therapy (TRT);   Radiation: Thoracic Radiation Therapy (TRT)
Sponsor:   Eli Lilly and Company
Recruiting - verified March 2010

Condition:   Alzheimer Disease
Interventions:   Drug: bapineuzumab;   Drug: placebo
Sponsor:   Wyeth
Recruiting - verified February 2010

Condition:   Alzheimer Disease
Interventions:   Drug: bapineuzumab;   Drug: placebo
Sponsor:   Wyeth
Recruiting - verified February 2010

Conditions:   Advanced Non-Small Cell Lung Cancer;   Transitional Cell Carcinoma;   Soft Tissue Sarcoma;   Gastric/Esophageal Adenocarcinoma;   Pancreatic Cancer Including Ampulla of Vater
Interventions:   Drug: brivanib;   Drug: Placebo
Sponsor:   Bristol-Myers Squibb
Recruiting - verified January 2010

Condition:   Sepsis
Interventions:   Drug: Drotrecogin alfa (activated);   Drug: Placebo
Sponsor:   Eli Lilly and Company
Recruiting - verified March 2010

Condition:   Non-Small-Cell Lung Cancer
Interventions:   Drug: Drug: pemetrexed;   Drug: Drug: erlotinib
Sponsor:   Eli Lilly and Company
Recruiting - verified March 2010

Condition:   Pain, Postoperative
Interventions:   Drug: pregabalin (Lyrica);   Drug: pregabalin (Lyrica);   Drug: matched placebo
Sponsor:   Pfizer
Recruiting - verified March 2010

Conditions:   Lymphoma;   Neutropenia;   Psychosocial Effects of Cancer and Its Treatment;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions:   Drug: amoxicillin-clavulanate potassium;   Drug: ciprofloxacin;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
Sponsor:   Clatterbridge Centre for Oncology
Recruiting - verified May 2007

Conditions:   Fabry Disease;   Cerebrovascular Accident
Intervention:   Other: No intervention
Sponsors:   University of Rostock;   Shire Human Genetic Therapies, Inc.
Recruiting - verified February 2010

Conditions:   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Liver Cancer
Interventions:   Drug: capecitabine;   Other: clinical observation;   Procedure: adjuvant therapy
Sponsor:   Southampton University Hospitals NHS Trust
Recruiting - verified March 2008

Condition:   Non Hodgkin Lymphoma
Interventions:   Drug: enzastaurin;   Drug: placebo
Sponsor:   Eli Lilly and Company
Recruiting - verified March 2010

Condition:   Sarcoma
Interventions:   Biological: dactinomycin;   Drug: busulfan;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: melphalan;   Drug: vincristine sulfate;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: conventional surgery;   Radiation: radiation therapy
Sponsors:   University Hospitals, Leicester;   National Cancer Institute (NCI);   Children's Cancer and Leukaemia Group;   Societe Francaise Oncologie Pediatrique;   European Organization for Research and Treatment of Cancer;   Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany;   Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria;   Swiss Group for Clinical Cancer Research;   EBMT Solid Tumors Working Party;   Children's Oncology Group
Recruiting - verified March 2010